Linkedin Facebook X-twitter
From Data to Discovery Uniting Africa Against Amyloidosis

My Account

LOG IN
open-navigation
close-navigation
Login / Signup
Dr. Souhila Ouabdesselam is a Consultant Cardiologist, cardio-oncologist, and cardio-geriatrician based in Algiers, Algeria, with extensive experience in cardiovascular medicine, academic teaching, and clinical research. She currently works at CHU Mustapha as a Consultant Cardiologist, where she has been practicing since 2012, and serves as a Lecturer at University of Algiers. She is also a hospital-university assistant professor affiliated with the University of Algiers, contributing to both undergraduate and postgraduate medical education.

Dr. Ouabdesselam has specialized expertise in cardio-oncology and cardio-geriatric medicine, with a strong focus on hypertension, cardiovascular imaging, and clinical research. Her academic and clinical background spans more than 15 years across hospital medicine, university teaching, and scientific investigation. Prior to her current academic and hospital appointments, she worked as a cardiologist at EPH Thenia in Boumerdes, Algeria, and also served as a Medical Director within the pharmaceutical sector in Algiers.

She completed advanced postgraduate training in Cardio-Oncology at Aix-Marseille University and is currently pursuing additional specialization in Cardio-Geriatrics through Sorbonne University. She earned her specialization in cardiovascular diseases from the University of Algiers and obtained her Doctor of Medicine degree from the National Institute of Medical Sciences in Algiers.

Dr. Ouabdesselam has contributed to scientific publications addressing cardiovascular imaging and hypertension management, including studies on global longitudinal strain decline in hypertensive patients with preserved ejection fraction and ambulatory blood pressure monitoring practices in Algeria.

As Country Lead for Algeria within Amyloidosis Africa, Dr. Souhila Ouabdesselam supports scientific collaboration, cardiovascular awareness initiatives, research development, and regional engagement across North Africa, contributing to efforts aimed at improving awareness, diagnosis, and research capacity for cardiac amyloidosis and related cardiovascular diseases across the African continent.